感染症学雑誌第80巻第6号

Key words: Streptococcus pyogenes, Streptococcus dysgalactiae subsp. equisimilis, rapid diagnosis

Key words: Streptococcus pyogenes, Streptococcus dysgalactiae subsp. equisimilis, rapid diagnosis Table 1 Strains evaluated Table 3 Comparison of sensitivity (CFU/mL) of 8 rapid diagnostic kits for detecting

研修コーナー

l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l

パーキンソン病治療ガイドライン2002

ドキュメント1

27

損保ジャパンの現状2011

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 62 63 64 65 66 67 68 69

2 7 ( ) µ

本文／扉１

プログラム

平成20年5月 協会創立50年の歩み　海の安全と環境保全を目指して 友國八郎 海上保安庁 長官 岩崎貞二 日本船主協会 会長 前川弘幸 JF全国漁業協同組合連合会 代表理事会長 服部郁弘 日本船長協会 会長 森本靖之 日本船舶機関士協会 会長 大内博文 航海訓練所 練習船船長 竹本孝弘 第二管区海上保安本部長 梅田宜弘

Program

ａｐｈｐ３７－１１＿プロ１／ｋｙ８６９５４３５４０４１０００５５９０

Œ{Ł¶/1ŒÊ −ªfiª„¾ [ 1…y†[…W ]

日本内科学会雑誌第96巻第11号

idwr2008_21

VanC 521 0.63 0.24 2.12 2.27 1.07 0.98 1.75 0.70 27.24 0.76 1.16 0.35 1.26 0.71 2SD 1SD 1SD 2SD A SD 0.21 0.58 3.02 7.02 1.89 0.70 0.20 0.72 0.11 0.37 0.43 0.04 0.79 0.39 5515 6.19 Streptococcus pyogenes

Ł\”ƒ-2005

第90回日本感染症学会学術講演会抄録（I）

2017_Eishin_Style_H01

81

感染症学雑誌第77巻第8号

1 2 µ Streptococcus pneumoniae µ S. pneumoniae µ S. pneumoniae pbp β β pbp1a pbp2x pbp2b pbp mefe ermb pbp pbp1a pbp2x pbp2b pbp pbp pbp pbp 2x pbp1a pbp2x pbp 2b mefe ermb pbp β pbp2x β β β µ µ pbp3 µ

GJG160842_O.QXD

株式会社ウェッズ

39th 1 2 39th 25,000 500 300 20,000 15,000 400 300 200 10,000 5,000 200 100 100 0 0 0 16,000 50 5 12,000 8,000 4,000 40 30 20 10 4 3 2 1 0 0 0 3 4 39th 5 6 39th 7 N E W P R O D U C T S 8 39th 9 10 CO.,LTD.

- 2 -

- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - A) B) C) D) E) F) - 10 - G) H) I) J) P - 11 - 001 1,416,0003/4 1,062,000 002 100,000 50,00023 1,150,000 2,100,000 200,000+ 100,0000.9 1,600,000 JA

腎不全-第22回.indd

‚æ62›ñ”©fi®”Ô‰Z‘p›ï‘Ü

Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood

Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood Fig.1 Distribution of the cases with bacterial meningitis by age and pathogens Chiba

NewsLetter-No2

2009 Aida et al. Caries Res 2006;40 2000 100 % 78.7 88.0 96.6 98.8 98.8 98.8 100.0 100.0 100 75 69.4 50 75.3 74.8 73.3 73.1 73.0 72.4 71.8 71.7 51.7 40.2 69.4 68.8 73.6 25 22.3 32.8 21.9 22.9 22.1

大谷教育福祉研究　３９号☆／１．熊野

2 5 4 30 846 418 428 SWLSPANAS e.g. 2012 e.g. 20062006 2011 a2011 b 2 20121 2 2 2 2011 c2012 1 Figure 1 2 2006 2 2 1966 20122006 2012 30 Figure 1 2 4 2 5 4 2012 2011 Diener1984 the Satisfaction with Life

ｎｓｇ０２－１３／ｋｙ０４５０５９３０１６０００３３２１０

φ φ φ φ κ κ α α μ μ α α μ χ et al Neurosci. Res. Trpv J Physiol μ μ α α α β in vivo β β β β β β β β in vitro β γ μ δ μδ δ δ α θ α θ α In Biomechanics at Micro- and Nanoscale Levels, Volume I W W v W

2016select追加小冊子_0704出稿0706修正.indd

-JPN3 -JPN3 -G1 -G1 -G3 -OP -OP -OP -G3 -G3 -G3 -G3 -G3 -L -L -G1 -JPN1 -OP -G3 -OP -JPN2 -G3 -JPN1 -G3 -G3 -L-L -L -L -G3 -L -L -G2 -L -G3 -G1 -G2 -G2 -G3 -L -G1 -G2 -G3 -G1 -G3 -L -L -L -G3 -G3 -L -G1

日歯雑誌（Ｈ２２・７月号）ＨＰ用／ｐ０６‐１６　クリニカル①　田崎

imageRUNNER ADVANCE C2230F/C2220/C2220F　はじめにお読みください

JPN 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 27 1 2 3 4 5 28 1 19 2 3 4 6 5 18 17 16 15 14 13 9 8 7 12 11 10 1 2 3 4 5 6 7 8 9

VOL. 20 NO. 5 CHEMOTHERAPY Methoxy-4-sulfanilamidopyrimidine (OS-3376) Sulfadimethoxine (SDM) Table 1. In vitro antibacterial activities of OS-3

VOL. 20 NO. 5 CHEMOTHERAPY 653 2-Methoxy-4-sulfanilamidopyrimidine (OS-3376) Sulfadimethoxine (SDM) Table 1. In vitro antibacterial activities of OS-3376, SDM, SIZ and SMZ against Gram-positive and negative

日本化学療法学会雑誌第61巻第6号

β Moraxella catarrhalis Escherichia coli Citrobacter Klebsiella pneumoniae Enterobacter cloacae Serratia marcescens Proteus Pseudomonas aeruginosa Acinetobacter Bacteroides fragilis β Haemophilus influenzae

日本化学療法学会雑誌第58巻第4号

Escherichia coli Enterococcus faecalisstreptococcus agalactiae Klebsiella pneumoniae Staphylococcus epidermidis E. colie. faecalispseudomonas aeruginosa K. pneumoniae S. agalactiae E. coli E. coli μ p

外国語教育センタージャーナル第9号

1. 1 35 45 2. 1 2 2 2013 5 1 31 2 40 3 37 4 40 2 17 2 5 165 148 9 4 4 4 3 1 Dörnyei(2001) 2 3 2 119 2 60 2 4 1 1 30 1 2 2 6 4 3 3.1 5 3 5 90 4 5 120 6 PPT K-POP 3.2 10 40 7 7 2005 10 8 5 9 6 7 3 5 8 9

第86回日本感染症学会総会学術集会後抄録（I）

κ κ κ κ κ κ μ μ β β β γ α α β β γ α β α α α γ α β β γ μ β β μ μ α ββ β β β β β β β β β β β β β β β β β β γ β μ μ μ μμ μ μ μ μ β β μ μ μ μ μ μ μ μ μ μ μ μ μ μ β

1BD BBLCRYSTAL RGP Aerococcus viridans Arcanobacterium pyogenes Bacillus cereus Bacillus licheniformis Bacillus megaterium Bacillus pumilus Bacillus s

111-245150-N-03 21400AMY00151000 20099 1 BD BBLCRYSTAL RGP BD BBLCRYSTAL RGP 4-A 2-A 1-A 4-B 2-B 1-B 4-C 2-C 1-C 4-D 2-D 1-D 4-E 2-E 1-E 4-F 2-F 1-F 4-G 2-G 1-G 4-H 2-H 1-H 4-I 2-I 1-I 4-J 2-J 1-J -D-

産衛誌57-4たより.indb

A89 26 7 1 9 4 33 1 87 A90 24 A91 23 ACOH2014 A92 4 1 2 3 4 5 6 7 A93 A94 A95 A96 A97 A98 A99 A100 A101 27 8 1 9 A102 4 33 A103 A104 26 3 140 27 1 A105 27 A106 A107 A108 A109 A110 A111 A112 A113 et al

437“ƒ

et al., et al., et al., et al., et al., et al., 2 et al., et al., et al., Lancet Pharmacol Res. et al. Jpn J Cancer Res. et al. Jpn J Cancer Res. et al. Tohoku J Exp Med. et al. Jpn Circ J. et al. Cancer

EF-S55-250mm f/4-5.6 IS II 使用説明書

プログラム

442号

感染症学雑誌第80巻第5号

Streptococcus dysgalactiae equisimilis β β β Streptococcus pyogenes Streptococcus agalactiae S. milleri Streptococcus anginosus Streptococcus constellatus constellatus Streptococcus constellatus pharyngis

1

1

1 911 9001030 9:00 A B C D E F G H I J K L M 1A0900 1B0900 1C0900 1D0900 1E0900 1F0900 1G0900 1H0900 1I0900 1J0900 1K0900 1L0900 1M0900 9:15 1A0915 1B0915 1C0915 1D0915 1E0915 1F0915 1G0915 1H0915 1I0915

放射線専門医認定試験（２００９・２０回）／ＨＯＨＳ‐０５（基礎二次）

180 ( 64 ) THE JAPANESE JOURNAL OF ANTIBIOTICS June 2011 A b group A Streptococcus: GAS GAS 10 meta-analysis 1) 2,3) GAS potential pathogens Tab

June 2011 THE JAPANESE JOURNAL OF ANTIBIOTICS 64 23 179 ( 63 ) A b cefditoren pivoxil 5 amoxicillin 10 1,2) 1,3) 1) 1) 1) 4) 5) 6) 7) 1) 2) 3) 4) 5) 6) 7) 2011 4 8 2007 5 2009 4 A b GAS cefditoren pivoxil

陦ｨ邏・2

5 1F2F 21 1F2F

.f.....V._...\

THE JAPANESE JOURNAL OF ANTIBIOTICS 48-8 Enterococcus avium 5Š, Corynebacterium xerosis 10Š, Corynebacterium pseudodiphtheriticum 10Š, Corynebacterium

THE JAPANESE JOURNAL OF ANTIBIOTICS 48-8 Enterobacter spp., Serratia spp., Burkholderia cepacia, Flavobacterium spp., Alcaligenes spp. THE JAPANESE JOURNAL OF ANTIBIOTICS 48-8 Enterococcus avium 5Š, Corynebacterium

WebIntellTN02.qxp (Page 1)

2004 Check Point Software Technologies Ltd. 1 2004 Check Point Software Technologies Ltd. 2 Webサーバ Webアプリケーション データベース Webアプリケーション データベース 2004 Check Point Software Technologies Ltd. 3 2004 Check Point Software

数学概論I

{a n } M >0 s.t. a n 5 M for n =1, 2,... lim n a n = α ε =1 N s.t. a n α < 1 for n > N. n > N a n 5 a n α + α < 1+ α. M := max{ a 1,..., a N, 1+ α } a n 5 M ( n) 1 α α 1+ α t a 1 a N+1 a N+2 a 2 1 a n

Erased_PDF.pdf

JPN-1

EF70-200mm f/2.8l IS II USM JPN JPN-1 a JPN-2 JPN-3 1. JPN-4 2. 3. JPN-5 4. JPN-6 5. JPN-7 6. JPN-8 7. JPN-9 JPN-10 8. 9. JPN-11 10. JPN-12 11. 12. 13. JPN-13 14. JPN-14 JPN-15 canon.jp/ef 050-555-90001

MP-E 65mm f/2.8 1-5× 使用説明書

MACRO PHOTO LENS MP-E 65mm f/2.8 1-5 JPN JPN-1 a JPN-2 JPN-3 1. 2. JPN-4 JPN-5 JPN-6 3. JPN-7 JPN-8 4. JPN-9 5. JPN-10 6. 7. JPN-11 8. JPN-12 canon.jp/ef 050-555-90001 JPN-13 CT1-7525-010 CANON INC. 2002

日本糖尿病学会誌第58巻第7号

l l l l β μ l l l l l l α l l l l l l l μ l l l α l l l l l μ l l l l l l l l l l l l l μ l l l l l β l μ l μ l μ l μ l l l l l μ l l l μ l l μ l l l α α l μ l l μ l α l μ l α l l l μ l l l μ l l μ l

本文／目次（裏白）

untitled

東井義雄記念館蔵書目録12

11 1 51 12 3 51 13 52 14 57 15 59 16 600 60 17 62 18 41 19 37 20 42 21 1 44 22 2 44 23 3 44 24 4 44 25 47 26 46 27 46 28 52 29 60 30 55 31 62 32 H3 33 46 34 32 35 42 36 44 37 45 38 38 39 38 40 41 41 44

日歯雑誌（Ｈ２８・８月号）別刷り／ポスターセッション　とびら

α P. gingivalis P. gingivalis αsmatgf- VEGF-A α in vitro μ Porphyromonas gingivalis in vitro Porphyromonas gingivalis β β β JBiolChem. μ μ μ β Porphyromonas gingivalis in vitro μ α β α

Microsoft PowerPoint - masayukiakiyama_20141103.pptx

2

FAX-2840 2 http://solutions.brother.co.jp/ https://myportal.brother.co.jp/ Version 0 JPN 2 3 4 5 2 3 4 6 2 3 2 3 2 3 2 3 7 8 2 3 2 3 9 2 3 2 3 2 3 2 3 0 2 3 2 3 2 3 4 2 3 2 2 3 2 5 6 2 3 2 3 2 3 2 3 7

防衛研紀要21-1_06Tani.indd

1940 15 1941 16 1942 17 1943 18 121 21 1 2018 12 1 2 1937 12 7 7 8 22 8 25 3 8 31 11 7 4 1938 13 1940 15 5 1940 15 10 6 1 8 1 1972 6 1991 2008 2007 19 2016 3 2 3 1 1968 33 4 68 5 1953 1 6 1940 10 1 15

14227H

ONLINE_MANUAL

JPN ii iii iv v 6 vi vii viii 1 CHAPTER 1-1 1 2 1-2 1 2 3 4 5 1-3 6 7 1-4 2 CHAPTER 2-1 2-2 2-3 1 2 3 4 5 2-4 6 7 8 2-5 9 10 2-6 11 2-7 1 2 2-8 3 (A) 4 5 6 2-9 1 2-10 2 3 2-11 4 5 2-12 1 2 2-13 3 4 5

ONLINE_MANUAL

JPN ii iii iv v vi 6 vii viii 1 CHAPTER 1-1 1 2 1-2 1 2 3 1-3 4 5 6 7 1-4 2 CHAPTER 2-1 2-2 2-3 1 2 3 4 5 2-4 6 7 8 2-5 9 10 2-6 11 2-7 1 2 2-8 3 (A) 4 5 6 2-9 1 2-10 2 3 2-11 4 5 2-12 1 2 2-13 3 4 5

内科９６巻３号★／ＮＡＩ３‐１（第２２回試験問題）

µ µ α µ µ µ µ µ µ β β α γ µ Enterococcus faecalis Escherichia coli Legionella pneumophila Pseudomonas aeruginosa Streptococcus viridans α β 正解表正解記号問題 No. 正解記号問題 No. e(4.5) 26 e 1 a(1.2) 27 a 2

n , , % , % % % IFRS ,659 1,118, ,582 (+ 12.4%) 98, ,552

n 213 IFRS IFRS IFRS IFRS IFRS IFRS 213 11,188 1,159 IFRS 213 11,182 1,116 1,5 657 69 78 214 n 213 213 4 1 214 3 31 1,236 1 1,182 12.4% 537 128 1,116 13.% 39 998 4.1% 31 69 4.8% IFRS 212 213 994,659 1,118,241

日本産科婦人科学会雑誌第64巻第12号

Key words: "Streptococcus milleri group", respiratory infection, viridans streptococci, oral flora, antibody assay

Key words: "Streptococcus milleri group", respiratory infection, viridans streptococci, oral flora, antibody assay Fig. 1 Distribution of species of viridans Streptococci in saliva from 20 healthy adults

N-03.indd

111-24514035-N-03 21300AMY00325000 20099 1 BD BBLCRYSTAL GP BD BBLCRYSTAL GP g/ 4-A 7--4-0.175 2-A -D- 4---D- 1.692 1-A L--7--4-1.7775 4-B L--7--4-2.182 2-B -D- 4---D- 1.6915 1-B L--7--4-1.4315 4-C L--7--4-2.3815

CHEMOTHERAPY Methicillin-resistant S.aureus(MRSA) coccus epidermidis 105 Streptococcus pyogenes E.faecali senterococcus avium Enterococcus faecium Str

cefaclor(ccl),cefuroxime(cxm),cefixime (CFIX),cefteram(CFTM),cefdinir(CFDN) pneumoniae,streptococcus pyogenes Moraxella catarrhalis,haemophilus influenzae,escherichia coli, Klebsiella pneumoniae,proteus

MM0512-河村.ind

51 12 2005313 Taxonomic changes of the genera Staphylococcus and Streptococcus on this decade. Yoshiaki KAWAMURA Staphylococcus aureus, Staphylococcus epidermidis MRSA MRSE Streptococcus pyogenes, Streptococcus

<B54CB5684E31A4E9C0CBA4E5AA6BC160BEE3B27AA544A5552E706466>

N1 2 3 1 16 17 18 19 20 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 4 2 38 39 40 41 42 44 45 46 47 48 50 51 52 53 54 55 56 57 58 59 60 61 5 3 62 63 64 65 66 68 69 70 70 72 74 75 76 77 78 80 81 82 83

新 川 川 河 川 整 備 計 画

1 2,400 BOD75/l 2 42 4510 45 51 17 10 '98 51 17 66 512 14 1,307 22,679 13,242 134ha 274 107 1.9 '98 24 25 858 24 768 106 80 10,235, 13,442 462.9ha 758 42 3 ha () () () 45 9,10 240.0 897 773 4.6 47 6,7,9

,235,002 66,417,260 6,446,764 5,939,253 31,725,023 31,933, , ,147 4,969,463 4,247,784 19,001,432 19,481, ,25

19 193 2 1 18 193 2 18 19 19331 20331 3,999,561 4,948,530 1,011,068 1,108,973 2,988,492 3,839,557 1,003,796 362,988 39,725 328,544 2,213,314 1,900,294 2,861 11,094 333,524 447,538 2,914,023 3,638,676 11,683

2

MFC-7340 1 2 http://solutions.brother.co.jp/ https://regist.brother.jp/ Version 0 JPN 2 3 4 STEP1 接 続 設 置 する 5 6 7 5 1 2 3 6 4 8 1 4 2 3 5 9 1 10 11 12 13 1 2 14 1 2 3 4 5 6 15 1 2 3 4 5 16 1 2 3 4 17

スライド タイトルなし

日本化学療法学会雑誌第57巻第5号

in vitro Key words Streptococcus pneumoniae β Haemophilus influenzae Escherichia coli I Table. Antibacteriallevofloxacinactivityagainstclinicalisolates Organism Year Susceptibility(%)(Numberofstrains)

日本化学療法学会雑誌第56巻第1号

β β β β β Streptococcus pneumoniaehaemophilus influenzaemoraxella catarrhalismycoplasma pneumoniaechlamydia pneumoniae β Key wordsβ mys nilc laci ngis Table. Assessmentschedule Parameters Patientcharacteristics

, CONTENTS ( 2)

212 212 4 1 212 9 3 4217 5 1 2122 2,34 134 9 CONTENTS 1 3 5 212 ( 2) 9 212 1 1 5 212 1 2 2,34 134 ( )19 9 212 1 18 5 2 12212 1 29 1 213 1 1 212 11 3 5 1, 1,5 5 1 15 2 1,247 1,29 1,247 97% 53% 119 134 PC

2.2 (1967) (1997,2003) 2.2 ( ) 11

( ) 2.1 10 2.2 (1967) (1997,2003) 2.2 ( ) 11 12 ( ) 90150 (684) (887) (1099) (1361) (1605) (1707) (1854) 21(1946) 8 2.3 (1854) 13 (1997) (1854.12.23) (M8.4) (24 ) (M8.4) 70,000 3000 ( ) 7 2 3 3 (,1997)

untitled

4 4 2011.3.1 1....1 1.1... 1 1.2... 1 1.3... 2 2....3 2.1... 3 2.1.1... 3 2.1.2... 5 2.2... 7 2.2.2... 9 2.2.3... 14 2.2.4... 17 2.2.5... 23 2.2.6... 26 2.2.7... 29 2.2.8... 30 2.2.9... 31 2.2.10... 32

Fig.1 Chemical structure of BAY o 9867

Fig.1 Chemical structure of BAY o 9867 CHEMOTHERAPY 43 Table 3 Antibacterial spectrum of gram negative bacteria Medium:Heart infusion agar (Nissui) Method:Agar dilution (Streak) CHEMOTHERAPY DEC 1985

00-1_表紙・目次

日本内科学会雑誌第97巻第7号

untitled

16 3,000 12 3 12 25 1 2 1,298 43.3 1 2 10 16 3 4 5 6 3 7 8 9 10 11 12 13 14 15 16 17 18 19 20 1 21 1 3 22 23 1 24 25 0 26 27 28 29 30 636 668 683 690 722 771 799 799 820 820 847 868 883 917 10 922 922

untitled